Barclays
CARL

Barclays’s Carlsmed CARL Stock Holding History

Barclays’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.1K Sell
1,777
-8,856
-83% -$107K ﹤0.01% 4618
2025
Q4 		$131K Buy
10,633
+1,021
+11% +$13.6K ﹤0.01% 4497
2025
Q3 		$129K Buy
+9,612
New +$131K ﹤0.01% 4537

Other funds holding CARL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KC
KCM Capital Shawnee, Kansas $622M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays's CARL Position: Q1 2026 in Review

Barclays reduced its Carlsmed (CARL) stake by 83% in Q1 2026, selling an estimated $107K and leaving 1,777 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4618.

Barclays first reported a position in CARL in Q3 2025 and has held it in 3 quarters since. The position peaked at $131K in Q4 2025. 66 funds tracked by Wall St. Rank hold CARL as of Q1 2026.

  • Barclays held 1,777 shares of Carlsmed worth $16.1K as of Q1 2026.
  • Barclays sold 8,856 Carlsmed shares in Q1 2026, an estimated $107K.
  • Carlsmed made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4618 holding.
  • Barclays first reported a position in Carlsmed in Q3 2025 and has held it in 3 quarters since.
  • Barclays's Carlsmed position peaked at $131K in Q4 2025.
  • 66 funds tracked by Wall St. Rank held Carlsmed as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.